Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q3KV
|
|||
| Former ID |
DNC012957
|
|||
| Drug Name |
2-amino-2-(2,3-difluorophenyl)acetic acid
|
|||
| Synonyms |
2-amino-2-(2,3-difluorophenyl)acetic Acid; 237424-16-7; 2,3-Difluoro-DL-phenylglycine; 2,3-DIFLUOR-DL-PHENYLGLYCINE; CHEMBL204804; AC1MC6PF; MolPort-000-165-847; JRD-0494; SBB090537; BDBM50179717; amino(2,3-difluorophenyl)acetic acid; AKOS012977999; AB26703; PS-11465; alpha-Amino-2,3-difluoro-benzeneacetic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H7F2NO2
|
|||
| Canonical SMILES |
C1=CC(=C(C(=C1)F)F)C(C(=O)O)N
|
|||
| InChI |
1S/C8H7F2NO2/c9-5-3-1-2-4(6(5)10)7(11)8(12)13/h1-3,7H,11H2,(H,12,13)
|
|||
| InChIKey |
DNWOZEQWCCXGRU-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Voltage-gated calcium channel alpha-2/delta-1 (CACNA2D1) | Target Info | Inhibitor | [1] |
| KEGG Pathway | MAPK signaling pathway | |||
| Cardiac muscle contraction | ||||
| Adrenergic signaling in cardiomyocytes | ||||
| Oxytocin signaling pathway | ||||
| Hypertrophic cardiomyopathy (HCM) | ||||
| Arrhythmogenic right ventricular cardiomyopathy (ARVC) | ||||
| Dilated cardiomyopathy | ||||
| Panther Pathway | Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||
| WikiPathways | Arrhythmogenic Right Ventricular Cardiomyopathy | |||
| miR-targeted genes in muscle cell - TarBase | ||||
| miR-targeted genes in lymphocytes - TarBase | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1138-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.